News from 340breport.com

Follow

News from 340breport.com

See all of 340breport.com news coverage in one place. Discover how 340breport.com’s media bias informs their coverage and compare with thousands of other news outlets.

In total, 50 have been published by 340breport.com which Ground News has aggregated in the past 3 months.

The Ground News media bias check for 340breport.com is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

If you want to know if 340breport.com is credible or reliable, look no further. We rank 340breport.com as unknown factuality. Find out more about our methodology here.

Follow

See all of 340breport.com news coverage in one place. Discover how 340breport.com’s media bias informs their coverage and compare with thousands of other news outlets. In total, 50 have been published by 340breport.com which Ground News has aggregated in the past 3 months.

The Ground News media bias check for 340breport.com is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides. If you want to know if 340breport.com is credible or reliable, look no further. We rank 340breport.com as unknown factuality. Find out more about our methodology here.

---

Information about 340breport.com

Where is 340breport.com located?340breport.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Average Factuality Rating: Unknown

Learn more about Factuality Ratings.

---

Top 340breport.com News

United States · United States

Former Senior Trump Official Talks Drug Pricing Reform, Says 340B Program Is ‘Out of Control’ - 340B Report

A key official in the former Trump administration raised serious concerns with the 340B program during the keynote address at [...] The post Former Senior Trump Official Talks Drug Pricing Reform, Says 340B Program Is ‘Out of Control’ appeared first on 340B Report.See the Story

Johnson & Johnson

Former J&J Attorney and Current Kalderos Board Director Says Battle over Rebates Has Not Ended - 340B Report

An influential drug industry expert said that he expects Johnson & Johnson to sue the government over its refusal to approve the drug giant’s controversial plan to change the 340B program from an upfront discount to a back-end rebate.  The remarks, from an attorney who used to represent Johnson & Johnson (J&J) in private practice, occurred during a panel discussion on hot button legal issues at the Association for Value-Based Cancer Care Annual …See the Story

Optimizing Your 340B Program: Ensuring Accurate Capture and Identifying Data Gaps - 340B Report

SPONSORED CONTENT The 340B Drug Pricing Program offers significant savings to eligible healthcare organizations, enabling them to stretch scarce resources [...] The post Optimizing Your 340B Program: Ensuring Accurate Capture and Identifying Data Gaps appeared first on 340B Report.See the Story

---

Latest News Stories

Topics Most Covered by 340breport.com

Johnson & Johnson

AstraZeneca

Medicare

Amgen

Eli Lilly

Johnson & Johnson

AstraZeneca

Medicare

Sources Covering Similar Topics

American Hospital Association

Endpoints News

healthcaredive.com

Pharmaphorum

American Hospital Association

Endpoints News

healthcaredive.com

Suggest a source

Looking for a source we don't already have? Suggest one here.

Breaking News Topics Related to 340breport.com

AstraZeneca

Johnson & Johnson

Amgen

Medicare

Eli Lilly

Louisiana

United States